(0.16%) 5 222.68 points
(0.32%) 39 513 points
(-0.03%) 16 341 points
(-1.34%) $78.20
(-2.13%) $2.25
(1.14%) $2 366.90
(0.11%) $28.40
(1.48%) $1 005.50
(0.11%) $0.928
(-0.30%) $10.83
(-0.01%) $0.798
(-0.42%) $92.15
Live Chart Being Loaded With Signals
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States...
Stats | |
---|---|
Today's Volume | 7 120.00 |
Average Volume | 51 129.00 |
Market Cap | 20.81M |
EPS | $0 ( 2024-05-09 ) |
Next earnings date | ( $-0.820 ) 2024-08-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.200 |
ATR14 | $0.0230 (1.28%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-02 | Dooley Mary Beth | Sell | 188 | Common Stock |
2024-04-02 | Awad Antoine | Sell | 372 | Common Stock |
2024-03-18 | Dooley Mary Beth | Sell | 0 | Common Stock |
2024-03-18 | Dooley Mary Beth | Sell | 3 612 | Stock Option (right to buy) |
2024-03-19 | Flynn James P | Buy | 4 000 | Stock Option (right to buy) |
INSIDER POWER |
---|
-63.68 |
Last 97 transactions |
Buy: 6 126 214 | Sell: 2 856 834 |
Synlogic Inc Correlation
10 Most Positive Correlations | |
---|---|
SJ | 0.953 |
PRSO | 0.947 |
SGML | 0.945 |
DCOM | 0.941 |
EXTR | 0.94 |
MATW | 0.939 |
HAFC | 0.938 |
SHBI | 0.936 |
KRNY | 0.932 |
CHTR | 0.931 |
10 Most Negative Correlations | |
---|---|
ATCX | -0.937 |
IIN | -0.927 |
MOR | -0.924 |
META | -0.921 |
TESS | -0.919 |
TA | -0.918 |
ECHO | -0.91 |
SGIIU | -0.909 |
TACO | -0.909 |
LIBY | -0.906 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Synlogic Inc Financials
Annual | 2023 |
Revenue: | $3.37M |
Gross Profit: | $-1.92M (-57.08 %) |
EPS: | $-8.81 |
FY | 2023 |
Revenue: | $3.37M |
Gross Profit: | $-1.92M (-57.08 %) |
EPS: | $-8.81 |
FY | 2022 |
Revenue: | $1.18M |
Gross Profit: | $-4.49M (-380.42 %) |
EPS: | $-13.57 |
FY | 2021 |
Revenue: | $1.75M |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-1.090 |
Financial Reports:
No articles found.
Synlogic Inc
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase II clinical trials to treat phenylketonuria; SYNB1353, an orally administered, non-systemically absorbed drug candidate to treat homocystinuria; and SYNB8802, an orally administered, non-systemically absorbed drug candidate that is in Phase I clinical trial for the treatment of enteric hyperoxaluria. The company is also developing SYNB1891, an intratumorally administered synthetic biotic medicine that is in Phase I clinical trial to treat solid tumors and lymphoma. It has a collaboration agreement with F. Hoffmann-La Roche Ltd; Hoffmann-La Roche Inc.; and Ginkgo Bioworks, Inc. Synlogic, Inc. is headquartered in Cambridge, Massachusetts.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators